National List Of Essential Medicines

Activists point that as the current drug pricing regime does not cover essential drugs in all their strengths and presentation, patients lose out on many counts

Exclusive | Prices of medicines used to treat common ailments set to increase steeply this year

Drugs and medical devices in the National List of Essential Medicines rise year-on-year price by 2-3 percent on average, but the increase may be steeper this year      Common antibiotics and medicines for treating fever and blood pressure are among drugs whose prices are expected to increase steeply this year 

Why pharma stocks lost their safe haven appeal this year

Pharmaceutical stocks have traditionally been considered defensive safe havens because demand for medicines doesn‘t depend on the economic cycle

Margins recovering; expect them to normalise around 20%: GSK

In an interview to CNBC-TV18, Andrew Aristidou, CFO of GlaxoSmithKline Pharmaceuticals spoke about the results and his outlook for the company.

New products, regulatory approvals to drive growth for Glenmark

The company is expecting strong growth in the current fiscal both from India and US. Major approvals are expected to drive growth for Glenmark, says Chairman and Managing Director Glenn Saldanha.

Drug pricing regime needs to be predictable,transparent:Sanofi

Government must not place the entire burden of access to healthcare on the pharmaceutical industry alone, Sanofi India has said while hitting out at more medicines being put under price control.

Drug formulations under price control rise to over 800

Officially confirming addition of over 200 formulations under price cap, the Department of Pharmaceuticals has notified amendment of the Schedule I of Drug Price Control Order (DPCO) 2013 for substituting the National List of Essential Medicines (NLEM) 2011 by NLEM 2015.

Govt to launch mobile app for info related to medicines

Government is planning a mobile application that will provide all information related to pricing and availability of medicines as well as addressing consumer grievances, Fertiliser Minister Ananth Kumar said on Thursday.

India reliant on China for 12 NLEM drugs' ingredients: Govt

"The decision to import and the country of origin for such imports are based on economic considerations, Kumar said.

Pricing mechanism to impact earnings of Pharma cos: ICRA

A market-based pricing mechanism is more acceptable to pharma industry and over a longer-period may limit the adverse impact on the industry, says ICRA.

Pharma M&A: Why has IMG proposed stiff riders?

The inter-ministerial group that was set up to clear FDI in pharma brownfield projects has come out with stringent guidelines that could impact pharma mergers and acquisitions in India, reports CNBC-TV18's Ronojoy Banerjee.

Pharma companies oppose inclusion of 348 drugs in NLEM

Union health ministry's plan to bring 348 drugs of the National List of Essential Medicines (NLEM) under price control is facing stiff resistance from the pharma industry, reports the Times of India.